Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,991 Million (Mid Cap)
24.00
NA
1.95%
-0.37
10.20%
2.12
Revenue and Profits:
Net Sales:
249 Million
(Quarterly Results - Jun 2025)
Net Profit:
100 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.34%
0%
24.34%
6 Months
15.72%
0%
15.72%
1 Year
18.6%
0%
18.6%
2 Years
-16.42%
0%
-16.42%
3 Years
58.31%
0%
58.31%
4 Years
17.77%
0%
17.77%
5 Years
-34.36%
0%
-34.36%
Jiangsu Jibeier Pharmaceutical Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.56%
EBIT Growth (5y)
13.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.42
Tax Ratio
13.72%
Dividend Payout Ratio
69.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.96%
ROE (avg)
9.21%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
2.49
EV to EBIT
21.26
EV to EBITDA
20.13
EV to Capital Employed
3.44
EV to Sales
5.46
PEG Ratio
23.77
Dividend Yield
2.49%
ROCE (Latest)
16.17%
ROE (Latest)
10.47%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
249.40
235.90
5.72%
Operating Profit (PBDIT) excl Other Income
70.10
80.10
-12.48%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
99.70
69.40
43.66%
Operating Profit Margin (Excl OI)
266.10%
327.10%
-6.10%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 5.72% vs -5.72% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 43.66% vs 19.24% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
883.60
850.50
3.89%
Operating Profit (PBDIT) excl Other Income
300.30
242.70
23.73%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
219.00
218.80
0.09%
Operating Profit Margin (Excl OI)
326.90%
271.00%
5.59%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 3.89% vs 31.76% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 0.09% vs 41.80% in Dec 2023
About Jiangsu Jibeier Pharmaceutical Co. Ltd. 
Jiangsu Jibeier Pharmaceutical Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






